FDA issues draft guidance on pre-determined change control plans By Israel Group on May 11, 2023 Posted in Uncategorized In a significant step forward, FDA has issued long-awaited draft guidance on pre-determined change control plans for AI/ML- enabled medical devices. Our alert looks at the guidance and the implications.